EUVIMEDEUVIMED entdecken
Crossref

Cancer‐Associated Fibroblast‐Derived RIPK4 Confers Cisplatin Resistance in Gastric Cancer by Activating the PI3K/AKT Pathway

Rui Chen, Junfang Dai, Bo Wang, Guofei Peng, Yao Xun, Yan Li iD

Journal of Biochemical and Molecular Toxicology · 2025-06 · 39 (6)

DOI: 10.1002/jbt.70320 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, online erschienen am 16.06.2025. Verfasst von Rui Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Laboratory, Central Hospital of Huanggang, Huanggang, China. Hauptthemen laut MEDLINE: Cisplatin, Stomach Neoplasms, Drug Resistance, Neoplasm, Proto-Oncogene Proteins c-akt. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer‐associated fibroblasts (CAFs) play a central role in cancer progression and are involved in modulating cancer cell proliferation, invasion, metastasis, drug resistance and so on. Receptor Interacting Serine/Threonine Kinase 4 (RIPK4) was demonstrated to promote gastric cancer (GC) metastasis and tumorigenesis. Here, this study aimed to explore whether GC‐derived CAFs affected cisplatin (DDP) resistance in GC cells via RIPK4. DDP‐resistant GC cells were first established. Levels of RIPK4 mRNA and proteins were detected using qRT‐PCR and western blotting. The IC50 values of DDP, cell proliferation, invasion, and migration were analyzed using MTT, 5‐ethynyl‐2′‐deoxyuridine, transwell, and wound healing assays, respectively. PI3K/AKT pathway‐related proteins were measured by western blotting. Animal experiments were performed for in vivo analysis. Here, we found that CAFs enhanced DDP resistance in DDP‐resistant cells by promoting cell proliferation, invasion and migration. CAFs led to an increased RIPK4 expression in DDP‐resistant cells. The silencing of RIPK4 suppressed DDP resistance in DDP‐resistant cells. Moreover, RIPK4 silencing in CAFs could also reduce DDP resistance in GC. Mechanistically, CAFs could activate the PI3K/AKT pathway by RIPK4. In vivo assay also showed that RIPK4 silencing in CAFs attenuated CAF‐induced DDP resistance. In conclusion, RIPK4‐decreased CAFs suppressed DDP resistance in GC by blocking the activation of the PI3K/AKT pathway, recommending a novel method for overcoming DDP resistance in gastric cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinStomach NeoplasmsDrug Resistance, NeoplasmProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesSignal TransductionCancer-Associated FibroblastsProtein Serine-Threonine KinasesNeoplasm ProteinsHumansCell Line, TumorAnimalsMiceCell ProliferationCell Movement

Stichwörter der Autor:innen

CAFsDDPPI3K/AKTRIPK4gastric cancer

Substanzen

CisplatinProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesRIPK4 protein, humanProtein Serine-Threonine KinasesNeoplasm Proteins

Autor:innen und Institutionen

  • Clinical Laboratory, Central Hospital of Huanggang, Huanggang, China.
  • Infections Disease Department, Central Hospital of Huanggang, Huanggang, China.

ORCID-Profile: Yan Li

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Chen, R., Dai, J., Wang, B., Peng, G., Xun, Y., & Li, Y. (2025). Cancer‐Associated Fibroblast‐Derived RIPK4 Confers Cisplatin Resistance in Gastric Cancer by Activating the PI3K/AKT Pathway. Journal of Biochemical and Molecular Toxicology, 39(6). https://doi.org/10.1002/jbt.70320

Vancouver

Chen R, Dai J, Wang B, Peng G, Xun Y, Li Y. Cancer‐Associated Fibroblast‐Derived RIPK4 Confers Cisplatin Resistance in Gastric Cancer by Activating the PI3K/AKT Pathway. Journal of Biochemical and Molecular Toxicology. 2025;39(6). doi:10.1002/jbt.70320

BibTeX
@article{Chen2025,
  author = {Chen, Rui and Dai, Junfang and Wang, Bo and Peng, Guofei and Xun, Yao and Li, Yan},
  title = {Cancer‐Associated Fibroblast‐Derived RIPK4 Confers Cisplatin Resistance in Gastric Cancer by Activating the PI3K/AKT Pathway},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2025},
  volume = {39},
  number = {6},
  doi = {10.1002/jbt.70320}
}
Kostenlos starten →